Ribosomal tRNA binding site

The ribosomal tRNA binding sites are structural features on the ribosome that facilitate binding and correct positioning of transfer RNAs (tRNAs) during translation. The ribosome consists of two subunits (30S and 50S in prokaryotes; 40S and 60S in eukaryotes) which assemble to create three primary tRNA binding sites: the A (aminoacyl), P (peptidyl), and E (exit) sites. Incoming tRNAs enter the A site, participate in peptide bond formation at the P site, and exit via the E site. These interactions are critical for the accurate synthesis of proteins from mRNA templates, with the small subunit (30S/40S) playing a particularly important role in codon–anticodon recognition and decoding, while the large subunit (50S/60S) mediates peptide bond formation. Antibacterial drugs can target these sites to disrupt protein synthesis, but "ribosome subunit binding tRNA" is not itself a single molecular drug target, gene, or receptor [1][2][3][4][7][9]. Clarification: - The phrase "Ribosome subunit binding tRNA" is not a canonical molecular target name, but rather refers to a biophysical interaction essential for translation. The correct target, if intended, should be more precisely named (such as "Ribosome," "Ribosomal A site," or "Peptidyl transferase center") [1][2][4]. - If the query intends a validated drug target, consider specifying the particular ribosomal RNA site, subunit, or function disrupted by antibiotics.

Other names

Ribosomal tRNA interaction siteRibosome–tRNA binding interfaceRibosomal A/P/E site

Inhibition of ribosomal function by interfering with proper tRNA binding or movement (e.g., trapping tRNA in the A or P site, blocking translocation, inhibiting peptide bond formation) [2][9]